Study linking alcohol consumption and the memory formation process
Dr. Thomas Kim, President and CEO of EpiVario, a preclinical pharmaceutical company, discusses the study published in “Nature” (Oct 2019) titled “Alcohol metabolism contributes to brain histone acetylation”. This new research is the first empirical evidence indicating a direct link between alcohol consumption and the memory formation process. Mice tested during the study showed a preference for alcohol when exposed to environmental cues to consume alcohol; and when this metabolic route was blocked, via the ACSS2 enzyme, this preference was eliminated. These new findings could pave the way for novel therapeutic interventions for alcohol use, fetal alcohol syndrome, and other neuropsychiatric disorders.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Thomas Kim is an experienced biotech executive and corporate attorney, and a registered patent attorney. He has lead EpiVario Inc. from a University of Pennsylvania startup in 2017, to a seed-funded, preclinical drug development company. He previously served as SVP and Corporate Secretary for a public biopharmaceutical company, Inovio Pharmaceuticals. Dr. Kim has counseled pharmaceutical and biotechnology companies for over 20 years. He has practiced law at two large law firms and at Fortune 100 companies including Monsanto and DuPont.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
